PHARMATECH (CAYMAN) >WX
SOURCE: Form 144
ISSUER: WUXI PHARMATECH (CAYMAN) INC
FILER: TIANDI GROWTH CAPITAL
BROKER: UBS FINANCIAL SERVICES INC
RESTRICTED SHARES TO SELL: 595,500 DATE REGISTERED: 2/5/2008
APPROXIMATE DATE OF SALE: 2/4/2008
The Form 144 is filed with the Securities and Exchange Commission to
reflect the intention of any holder of restricted stock to sell those
shares. After the 144 is mailed to the S.E.C., the filer is permitted
to sell the shares, or any fraction of them, within 90 days.
Form 144 Data Source: The Washington Service
(firstname.lastname@example.org or 301-913-5100)
(END) Dow Jones Newswires
By the way, you just short visit to China, what do you really know China and Chinese people. People over there take care of their health is much more serious than you do. Babyboomers are getting old. Let's see their eaning, have to be good.
If you talk about the P/E, Go short ILMN. Their P/E is N/A but the price is around $70. You suppose get a big $ there if you have the guts and your logic here is right. When you will get a hit, don't blame me. I followed your mind here. WX is one of the biggiest 9 drug companies in the world and has it reputation, how could you compare it with a game software company China?